A Phase II Exploratory Study Evaluating the Efficacy of Topical Cromoglicate Solution Compared to Topical Solution Vehicle in the Treatment of Mastocytosis
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2013
Price : $35 *
At a glance
- Drugs Cromoglicate lisetil (Primary)
- Indications Systemic mastocytosis; Urticaria pigmentosa
- Focus Pharmacogenomic; Therapeutic Use
- 01 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Oct 2012 New trial record
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.